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Introduction
Cardiac resynchronisation therapy (CRT) has become an 
important treatment for patients with heart failure and left 
ventricular (LV) dyssynchrony [1–3]. However, clinical 
non-response to CRT is reported in 25–35 % of patients. 
Although a large variety of causes for a suboptimal response 
have been cited, most attention has been focused on the 
selection of patients eligible for CRT, and less on inadequate 
delivery of CRT therapy [4]. However, even with growing 
experience and improved materials and tools, the optimal 
position cannot always be reached in one of the tributaries 
of the coronary sinus. This can be due to the absence of suit-
able side branches in the posterolateral area, coronary vein 
stenosis, lead instability, high stimulation threshold, phrenic 
nerve stimulation, or a combination of the above [5–7].
We studied the acute haemodynamic response (AHR) of 
the implanted system and alternative left ventricular endo-
cardial pacing sites in patients clinically not responding to 
CRT [8].
Patients and methods
We asked patients who remained in New York Heart Fail-
ure class III or IV despite at least 6 months of CRT and 
adequate medical therapy and with no therapeutic options 
left to undergo an acute haemodynamic study in search 
of improving existing CRT, as previously described 
[8, 9]. Twenty-four non-consecutive patients, 23 males, age 
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72.8 ± 9.1 years, mean ejection fraction 22.5 ± 7.1 %, agreed 
to undergo this test (Table 1). The ECG prior to implantation 
showed left bundle branch block (LBBB) in 12, non-LBBB 
in 4, and right ventricular (RV) pacing in 8 patients.
In 23 patients, a 6F multipurpose angioplasty guiding 
catheter was introduced into the LV after a standard trans-
septal catheterisation. In one patient, the guiding catheter 
was introduced through the radial artery following coro-
nary angiography. Through this guiding catheter, endo-
cardial pacing and measurements of LVdP/dtmax were 
accomplished by roving a Medtronic 6416 temporary bipo-
lar screw-in lead (Medtronic Inc. Minneapolis, MN.) and 
a RADI pressure wire (RADI Medical, a St Jude Medical 
Company, St. Paul, MN) inside the LV cavity.
Initially the atrioventricular and interventricular intervals 
of the implanted system were optimised to obtain the maxi-
mal LVdP/dtmax. LV pacing was performed from basal 
posterolateral, mid-posterolateral, LV apical and LV septal 
locations, and optimal AHR obtained after optimisation of 
the CRT system for all positions. If none of the 4 endocardial 
positions were opposite the position of the coronary sinus 
lead, an additional measurement was done at this location. 
A rise in LVdP/dtmax ≥ 15 % from baseline was considered 
to be a positive haemodynamic response.
In all patients with an AHR of ≥ 15 % during LV endocar-
dial pacing, the interval between the onset of the QRS com-
plex and the intrinsic activation at the LV electrode (Q-LV 
interval) was measured and the ratio between Q-LV/QRS 
width interval calculated. This ratio expresses the relation 
between Q-LV interval and QRS width, which is a better 
indicator for late or early LV sensing than the absolute value 
of Q-LV.
Results
Acute haemodynamic response of the total study 
population
Notwithstanding that all patients were clinical non-respond-
ers, in 5 patients LVdP/dtmax with the implanted coronary 
sinus system increased ≥ 15 % after optimisation: average 
30.2 %, 15.6–44.5 % (Table 2). In 3 out of these 5 patients 
with the coronary sinus lead in a posterolateral position, 
endocardial pacing did not increase the LVdP/dtmax sub-
stantially (AHR less than 3 % and even an adverse effect 
from LV endocardial pacing was observed in one patient). 
In one of the two remaining patients with an apical posi-
Table 1 Characteristics of clinical non-responders (24 patients)
Patient Gender Age (Years) NYHA Class ICM/DCM Ejection fraction (%) QRS morphology QRS width (ms)
Pt. 01 M 56 IV DCM 13 LBBB 135
Pt. 02 M 78 III–IV ICM 17 RVP 225
Pt. 03 M 75 III ICM 12 LBBB 174
Pt. 04 M 70 III ICM 19 RVP 196
Pt. 05 M 81 II–III ICM 26 LBBB 165
Pt. 06 M 79 III ICM 18 Non-LBBB 170
Pt. 07 M 74 III–IV ICM 28 Non-LBBB 175
Pt. 08 M 87 III ICM 42 LBBB 154
Pt. 09 M 79 III–IV ICM 14 LBBB 209
Pt. 10 M 75 III DCM 33 RVP 172
Pt. 11 M 55 III DCM 30 LBBB 149
Pt. 12 M 81 III ICM 14 LBBB 198
Pt. 13 F 72 III DCM 23 RVP 152
Pt. 14 M 74 III ICM 20 LBBB 152
Pt. 15 M 82 III–IV DCM 25 RVP 200
Pt. 16 M 82 III–IV DCM 25 Non-LBBB 175
Pt. 17 M 83 III ICM 22 LBBB 192
Pt. 18 M 71 III ICM 30 Non-LBBB 180
Pt. 19 M 71 III ICM 17 RVP 166
Pt. 20 M 55 III–IV ICM 20 LBBB 156
Pt. 21 M 66 III–IV ICM 26 LBBB 174
Pt. 22 M 75 III–IV ICM 22 LBBB 175
Pt. 23 M 61 III ICM 27 RVP 160
Pt. 24 M 64 III–IV ICM 17 RVP 210
Average 23M/1F 72.8 ± 9.1 3.2 ± 0.3 6DCM 22.5 ± 7.1 12LBBB/8RVP 175 ± 22
Patient characteristics of 24 clinical non-responders to CRT.
NYHA class New York Heart Association Class, DCM dilated cardiomyopathy, ICM ischaemic cardiomyopathy, LBBB left bundle branch block, 
non-LBBB non left bundle branch block, pt. patient, RVP right ventricular pacing.
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169 ms (135–198 ms) and the average Q-LV at the optimal 
LV endocardial pacing site 157 ms (128–176 ms), resulting 
in a Q-LV/QRS ratio of 93 %. The position of the original 
coronary sinus lead was apical in 3, anterolateral in 1 and 
mid-posterolateral in 1 patient (Fig. 2).
In the remaining 4 patients, the average AHR at the opti-
mal endocardial position increased < 15 %, with an aver-
age of 7.3 % (1.7–9.9 %). The average QRS width in these 
patients was 176 ms (149–209 ms) and the average Q-LV 
136 ms (100–174 ms), resulting in a Q-LV/QRS ratio of 
83 %. The coronary sinus lead position was posterolateral 
in all 4 patients.
Non-responders with non-LBBB
Four patients did not have LBBB. Of these, only one patient 
with RBBB, combined with left anterior hemiblock, showed 
an increase in the AHR, from − 9.1 % (apical coronary sinus 
position) to 25.8 % at an endocardial basal posterolateral 
position. Two of the other patients had an RBBB pattern 
(Fig. 3); one had a non-specific intraventricular conduction 
tion of the coronary sinus lead, the AHR could be increased 
during LV endocardial pacing from 19.7–66 % and we con-
sidered the increase sufficient to justify the upgrade to LV 
endocardial pacing (Fig. 1).
In the 19 patients with an AHR from the implanted system 
< 15 %, 9 patients had an increase in AHR above the 15 % 
limit. The results of the total group of 24 patients showed a 
positive response in 11 patients with an apical lead position 
in 7, anterolateral in 2 and mid-posterolateral in 2 patients.
A negative response of endocardial pacing was observed 
in 13 patients with a basal posterolateral lead position in 3, 
mid-posterolateral in 8 and apical in 2 patients.
Non-responders with LBBB
In 5 out of the 9 acute haemodynamic non-responders 
(AHR < 15 %) with LBBB, the AHR could be increased 
above the 15 % level by LV endocardial pacing. The aver-
age AHR with the coronary sinus system was 9.6 % (5.8–
14.9 %) and at the LV endocardial optimal position 25.8 % 
(19.0–34.3 %). The average QRS width in these patients was 













Pt. 01 LBBB 1177 PL-mid 5.8 2.7 PL-bas 24.2
Pt. 02 RVP 780 PL-mid 4.0 4.0 PL-bas 11.4
Pt. 03 LBBB 659 Ant-lat 6.4 8.0 PL-bas 31.6
Pt. 04 RVP 949 Ant-lat 9.3 9.7 PL-mid 24.8
Pt. 05 LBBB 918 LV apical 10.0 12.7 PL-bas 20.1
Pt. 06 Non-LBBB 1259 LV apical 1.8 5.7 LV apical 5.7
Pt. 07 Non-LBBB 893 PL-mid − 23.4 – LV septal − 21.5
Pt. 08 LBBB 827 PL-bas 44.9 51.0 PL-bas 51.0
Pt. 09 LBBB 1113 PL-bas − 21.7 − 2.9 LV apical 1.7
Pt. 10 RVP 1378 PL-mid 3.5 4.6 PL-bas 9.8
Pt. 11 LBBB 986 PL-mid 7.3 2.9 PL-bas 10.9
Pt. 12 LBBB 1159 LV apical 14.9 16.6 PL-mid 19.0
Pt. 13 RVP 1126 PL-mid 11.6 16.6 PL-mid 16.6
Pt. 14 LBBB 1024 PL-mid 3.6 6.8 PL-mid 6.8
Pt. 15 RVP 599 LV apical 19.7 23.8 PL-bas 66.0
Pt. 16 Non-LBBB 790 LV apical − 9.1 -0.6 PL-bas 25.8
Pt. 17 LBBB 784 PL-bas 2.7 9.4 PL-mid 9.9
Pt. 18 Non-LBBB 929 LV apical 8.2 4.8 LV apical 4.8
Pt. 19 RVP 807 LV apical 1.1 – PL-mid 7.8
Pt. 20 LBBB 1028 PL-mid 15.6 16.7 PL-bas 19.7
Pt. 21 LBBB 475 PL-mid 46.7 34.9 PL-mid 34.9
Pt. 22 LBBB 799 LV apical 8.2 15.6 PL-bas 34.3
Pt. 23 RVP 439 LV apical 23.9 26.7 PL-mid 31.0
Pt. 24 RVP 489 LV apical 12.7 17.2 PL-mid 24.1
Average 891 ± 247 8.7 ± 15.8 10.5 ± 8.9 19.6 ± 17.5
Haemodynamic measurements of 24 clinical nonresponders to CRT.
Baseline LVdP/dtmax LVdP/dtmax with intrinsic rhythm or right ventricular pacing, AHR CS lead acute haemodynamic response from the 
coronary sinus (CS) lead expressed as percentage rise in LVdP/dtmax from baseline, AHR CS level endo acute haemodynamic response at an 
endocardial location opposite the CS lead, LV endo optimal position anatomic site with the highest AHR, AHR LV endo Acute haemodynamic 
response from the optimal endocardial position. Grey shaded patients have an AHR from the CS lead ώ 15 % and are considered haemodynamic 
responders, PL-bas basal posterolateral, PL-mid mid-posterolateral, RVP right ventricular pacing.
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Fig. 2 Recordings of the tempo-
rary study of patient no. 22 with 
a LBBB showing the haemody-
namic effects and the timing of 
the LV endocardial electrogram 
from the different positions
 
KEY MESSAGE  Increased hemodynamic response by left ventricular endocardial pacing 
Angiographic pictures of the haemodynamic study in patient no. 15. All views are in left anterior oblique (LAO)
showing the haemodynamic effects of stimulation from the coronary sinus lead and LV endocardial stimulation
in the mid-posterolateral area (left upper panel), basal posterolateral area (left lower panel), LV septum (right
upper panel) and lead positions after LV endocardial implantation of a permanent lead in the LV basal
posterolateral segment. Arrows indicate the position of the bipolar pacing lead
Figure 1
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sinus leads were in an apical, anterolateral and mid-pos-
terolateral position. In the other 3 patients the average AHR 
increased from 2.9 % (1.1–4.0 %) to 9.7 % (7.8–11.4 %). In 2 
patients the coronary sinus lead was in a mid-posterolateral 
position, one in an apical position. Individual details are 
summarised in Table 2 and a flow chart overview in Fig. 4.
delay with a QRS complex of 175 ms. The coronary sinus 
lead position was mid-posterolateral in 2 and apical in 1 
patient.
Non-responders with right ventricular pacing
Three out of the 6 patients with RV pacing became hae-
modynamic responders (LV dP/dtmax from average 9.7 %, 
(9.3–12.7 %) increased to 21.8 % (16.6–24.8 %)). Coronary 
Fig. 3 Recordings of a temporary 
study of patient no.18 with non-
LBBB, showing the haemody-
namic effects and the timing of 
the LV endocardial electrogram 
from the different positions. This 
recording illustrates that there is 
no conduction delay in the LV 
and a minimal haemodynamic 
effect
 
 Fig. 4 Flow chart of the study 
showing the haemodynamic re-
sults in relation to the coronary 
sinus lead positions. AHR acute 
haemodynamic response, Ant 
lat anterolateral, bas basal, CS 
coronary sinus, endo endocardial, 
LBBB left bundle branch block, LV 
left ventricular, PL posterolateral, 
pts patients, RV right ventricular
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(128–205 ms). The average Q-LV/QRS width ratio, which 
is Q-LV expressed as a percentage of QRS width, was 
90 %. The individual results of these data are summarised 
in Table 3.
Follow-up
Ten patients were considered possible candidates for LV 
endocardial pacing: 9 patients in whom a rise in LVdP/
dtmax ≥ 15 % level was only obtained by endocardial pac-
ing, and the patient that showed a substantial additional rise 
in AHR with LV pacing compared with coronary sinus pac-
ing (patient 15). One patient died from progressive heart 
failure before the endocardial implant could be performed.
Of the remaining 9 patients, and after deliberation with 
the patients about the possible benefits and risks, 5 of them 
finally agreed to LV endocardial implant at the optimal LV 
site as indicated from the acute study [9]. All five patients 
improved clinically with a reduction of at least 1 class in the 
NYHA score after 6 months of follow-up. Two patients with 
a positive response in the temporary study refrained from 
implantation of an LV endocardial lead.
One patient with a positive AHR from endocardial pac-
ing also improved significantly after changing stimulation 
from the distal to the proximal electrode with a more basal 
position, and became a clinical responder after optimisation 
of the atrioventricular and interventricular interval.
In one patient, the deterioration of his condition after 
initial improvement proved to be the result of a blunted 
chronotropic response after increasing beta-blocker dos-
age following an episode of atrial fibrillation resulting in an 
Epicardial vs endocardial haemodynamics
When pacing endocardially, opposite the epicardial coro-
nary sinus lead, we found that LVdP/dtmax did not dif-
fer significantly for any of the patients: LVdP/dtmax 
from the coronary sinus averaged 1046 ± 292 mmHg/s vs. 
1068 ± 296 mmHg/s from the corresponding LV endocardial 
site (p = 0.37).
Haemodynamics during endocardial pacing from different 
locations
We found that basal or mid-posterolateral segments had the 
highest AHR of the tested endocardial sites in all 14 patients 
who showed an AHR ≥ 15 % rise in LVdP/dtmax compared 
with baseline. Because either the basal or mid-posterolat-
eral segment had the highest AHR, we also calculated the 
combined best results from basal posterolateral and mid-
posterolateral (PL-best). PL-best had a rise to 30.2 ± 13.6 % 
in LVdP/dtmax, basal posterolateral 27.7 ± 15.2 %, mid-
posterolateral 24.6 ± 12.6 %, LV apical 14.8 ± 9.1 % and LV 
septal 17.0 ± 11.2 %.
Haemodynamic effect and Q-LV interval
We also found that in 12 out of the 14 patients (85 %) with 
an AHR ≥ 15 %, the LV endocardial site with the longest 
time interval between the onset of the QRS complex and LV 
sensing (Q-LV interval) resulted in the best haemodynamic 
response [10]. The average QRS width was 133 ± 22 ms 
(range 120–205 ms) and average Q-LV interval 155 ± 26 ms 
Table 3 Haemodynamic results for all 4 endocardial locations and maximum Q-LV interval for 14 patients that showed a rise in LVdP/dtmax 
≥ 15 % from endocardial pacing
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Pt.01 24.2 24.2 2.7 1.7 2.1 135 128 PL-bas
Pt.03 31.6 31.6 25.8 4.8 26.1 174 165 PL-bas
Pt.04 24.8 18.7 24.8 14.2 19.6 196 205 PL-mid
Pt.05 20.1 20.1 18.0 18.1 11.8 165 163 PL-mid
Pt.08 51.0 51.0 46.0 22.0 29.2 154 138 PL-bas
Pt.12 19.0 13.5 19.0 17.6 13.7 198 176 PL-mid
Pt.13 16.5 5.3 16.6 8.8 9.6 152 128 PL-mid
Pt.15 66.0 66.0 50.2 31.3 47.3 200 181 PL-mid
Pt.16 25.8 25.8 14.1 − 0.6 12.2 175 147 PL-bas
Pt.20 19.7 19.7 16.7 8.9 16.3 156 124 PL-mid
Pt.21 34.9 28.0 34.9 16.9 6.9 174 132 PL-mid
Pt.22 34.3 34.3 20.3 15.6 14.4 175 155 PL-bas
Pt.23 31.0 26.2 31.0 26.7 18.6 160 138 PL-mid
Pt.24 24.1 22.9 24.1 17.2 11.5 210 192 PL-mid
30.2 ± 13.6 27.7 ± 15.2 24.6 ± 12.6 14.8 ± 9.1 17.1 ± 11.2 173 ± 22 155 ± 26
AHR Acute haemodynamic response expressed as the percentage rise in LVdP/dt from baseline, PL-best best result from either basal 
posterolateral (PL-bas) or mid-posterolateral (PL-mid) region, Max Q-LV longest interval measured between onset of the QRS complex and 
intrinsic activation at the LV electrode. Location of this electrode is indicated in last column. Grey shaded area indicates 2 patient in whom the 
longest Q-LV interval did not correspond with the best haemodynamic response.
91Neth Heart J (2016) 24:85–92
haemodynamic response can still be significantly improved 
in the presence of an anterior or apical lead position [10]. A 
similar discrepancy is found with echocardiography as the 
observed presence or absence of decrease in LV end-dia-
stolic volume or end-systolic volume and clinical response 
does not always correlate [17].
To err on the safe side, we therefore proceeded to a per-
manent LV endocardial implantation when the final increase 
in AHR was at least 25 %. There was no clinical evidence 
for the choice of this percentage.
The best AHR correlates well with the longest time inter-
val between onset QRS and LV sensing in relation to the 
QRS width in the individual patient [18].
The results of the group of patients with non-LBBB are 
in line with what could be expected according to the lit-
erature [19]. The absence of response correlated well to the 
lack of conduction delay in any of the LV segments on the 
intracardiac LV electrogram. The only responder to endo-
cardial pacing in this group had a significant LV conduction 
delay due to the left anterior hemiblock that accompanied 
RBBB. It is therefore questionable if one should proceed 
with endocardial mapping in this cohort of patients given 
the disappointing results [19].
Conclusions
This observational study showed that a temporary acute 
haemodynamic study could be useful in non-responders to 
establish the chance of improvement with alternative pac-
ing sites before embarking on complex procedures as endo-
cardial LV pacing. It remains, however, uncertain what the 
optimal cut-off value for increase in LVdP/dtmax is before 
the improvement justifies intervention. The longest Q-LV 
interval is a reliable indicator for the optimal electrode posi-
tion in the individual patient.
Endocardial pacing opposite epicardial sites does not show 
acute haemodynamic improvement, so epicardial pacing at 
the optimal site may be a good alternative for endocardial LV 
lead placement. Although all patients who had a LV endocar-
dial system implanted after a positive AHR improved clini-
cally, larger randomised series are necessary to justify this 
technique before definitive conclusions can be drawn.
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inappropriate ICD shock. Activation of sensor driven pac-
ing restored his clinical status to the former level.
Discussion
This observational study showed that endocardial LV pac-
ing, guided by acute haemodynamic studies, could improve 
clinical outcome in patients not responding to conventional 
CRT. It also demonstrated the importance of lead location, 
as the clinical response improved with a posterolateral posi-
tion of the lead instead of the original apical or anterolat-
eral lead location. Conversely, none of the patients who 
already had a coronary sinus lead in a posterolateral posi-
tion improved sufficiently with endocardial pacing at any 
site during the acute haemodynamic study to justify endo-
cardial lead implant. This is in line with the MADIT-CRT 
trial, where the apical and anterior positions of the LV lead 
had a lower clinical response [10].
Noteworthy, and similar to what has previously been 
reported, endocardial pacing opposite the coronary sinus 
pacing site did not improve the AHR in our study [11–13]. 
This is in contrast with animal experiments that show sig-
nificantly better haemodynamic results with endocardial 
vs. epicardial pacing at the same location [14]. There is no 
clear single cause for this difference and it is most probably 
related to variance in the anatomical and electrophysiologi-
cal substrate. Besides this, in animal experience the lead 
configuration guarantees an exact position of the endocar-
dial lead opposite to the epicardial position; this in contrast 
with human studies in which the endocardial lead is placed 
as close as possible to its epicardial counterpart.
Therefore, although not examined in this and other stud-
ies, one either might speculate that epicardial pacing oppo-
site the optimal endocardial sites, via the coronary sinus or 
surgically by thoracoscopy, might have resulted in similar 
benefits. If feasible, this might be a good alternative to avoid 
the uncertainty of thromboembolic complications with LV 
endocardial pacing [15].
Our observational study also showed some limitations in 
the use of acute haemodynamic studies to predict clinical 
outcome. First, five clinical non-responders showed a clear 
AHR according to the accepted criteria (even with the higher 
than usual cut-off value of 15 % increase in LVdP/dtmax to 
exclude borderline cases) but failed to respond clinically [16].
Still, when a substantial further increase in LVdP/dtmax 
from endocardial pacing at a posterolateral position com-
pared with the apical coronary sinus lead (66 vs. 19.7 %) 
was obtained in one patient, endocardial lead implantation 
resulted in a positive clinical response. This illustrates the 
limitation of cut-off values in CRT studies of the 15 % level 
as surrogate for differentiating between clinical response 
and non-response, and that what is considered a positive 
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